Evidence for β(1)-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal

We previously showed that betaxolol, a selective β(1)-adrenergic receptor antagonist, administered during early phases of cocaine abstinence, ameliorated withdrawal-induced anxiety and blocked increases in amygdalar β(1)-adrenergic receptor expression in rats. Here, we report the efficacy of betaxol...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudoy, Carla A., Reyes, Arith-Ruth S., Van Bockstaele, Elisabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660858/
https://www.ncbi.nlm.nih.gov/pubmed/18596687
http://dx.doi.org/10.1038/npp.2008.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660858/
https://www.ncbi.nlm.nih.gov/pubmed/18596687
http://dx.doi.org/10.1038/npp.2008.102

Ejemplares similares